Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-22-071291
Filing Date
2022-03-10
Accepted
2022-03-10 07:31:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 POS AM d200554dposam.htm POS AM 245584
2 EX-5.1 d200554dex51.htm EX-5.1 4360
3 EX-23.1 d200554dex231.htm EX-23.1 1852
4 GRAPHIC g200554g0309080136983.jpg GRAPHIC 3024
5 GRAPHIC g200554g0309080138423.jpg GRAPHIC 5156
  Complete submission text file 0001193125-22-071291.txt   264464
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-253175 | Film No.: 22727406
SIC: 2834 Pharmaceutical Preparations